Achieve Life Sciences, Inc.
ACHV· Nasdaq
Filed Nov 10, 2016 · 10-Q · 41 days after period end · 0001564590-16-028946
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Net Income | -$268.00K | -$4.55M | -$4.91M | -$10.05M |
| EPS Diluted | -$12.62 | $0.16 | -$0.23 | -$0.68 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 10, 2016 · 41 d after period end